Compare GHRS & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GHRS | METC |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | Ireland | United States |
| Employees | N/A | 900 |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 1.0B |
| IPO Year | 2021 | N/A |
| Metric | GHRS | METC |
|---|---|---|
| Price | $22.53 | $13.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $41.38 | $34.00 |
| AVG Volume (30 Days) | 213.0K | ★ 1.4M |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.61 |
| Revenue Next Year | N/A | $11.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.67 | $8.51 |
| 52 Week High | $24.66 | $57.80 |
| Indicator | GHRS | METC |
|---|---|---|
| Relative Strength Index (RSI) | 64.60 | 40.09 |
| Support Level | $12.52 | N/A |
| Resistance Level | $22.88 | $16.20 |
| Average True Range (ATR) | 1.41 | 1.08 |
| MACD | -0.10 | -0.18 |
| Stochastic Oscillator | 70.20 | 4.58 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.